HIVE Blockchain Technologies Ltd. (CVE:HIV – Free Report) – Equities researchers at Roth Capital upped their Q4 2026 earnings estimates for shares of HIVE Blockchain Technologies in a report issued on Monday, January 6th. Roth Capital analyst D. Aftahi now anticipates that the company will post earnings per share of $0.04 for the quarter, up from their previous estimate of $0.03. Roth Capital has a “Strong-Buy” rating on the stock.
HIV has been the topic of a number of other research reports. Northland Capmk upgraded HIVE Blockchain Technologies to a “strong-buy” rating in a research note on Thursday, September 19th. Cantor Fitzgerald upgraded HIVE Blockchain Technologies to a “strong-buy” rating in a report on Tuesday, October 29th.
HIVE Blockchain Technologies Stock Performance
HIVE Blockchain Technologies Ltd. is a services company in the Business Services industry.
Recommended Stories
- Five stocks we like better than HIVE Blockchain Technologies
- High Flyers: 3 Natural Gas Stocks for March 2022
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- What is a Death Cross in Stocks?
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- 3 Best Fintech Stocks for a Portfolio Boost
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
